Fertility preservation in women - A practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT

Archives of Gynecology and Obstetrics

Volumn 284, Issue 2, 2011, Pages 427-435

  Von Wolff, Michael ^a   Montag, Markus ^b   Dittrich, Ralf ^c   Denschlag, Dominik ^d   Nawroth, Frank ^e   Lawrenz, Barbara ^f  

^a Universitats Frauenklinik   (Switzerland)

^b University Women's Hospital   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d Hochtaunus Kliniken   (Germany)

^e Hormon und Pränatalzentrum   (Germany)

^f University Women's Hospital   (Germany)

Author keywords

Cancer; Cryopreservation; Fertility preservation; GnRH agonists; Oocytes; Ovarian tissue

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LETROZOLE; METHOTREXATE; PREDNISONE; PROCARBAZINE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; VINBLASTINE; VINCRISTINE SULFATE;

AMENORRHEA; BONE MASS; BREAST CANCER; CANCER SURGERY; CLINICAL PRACTICE; CRYOPRESERVATION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; FEMALE FERTILITY; FERTILIZATION; GYNECOLOGIC SURGERY; HEALTH CARE ORGANIZATION; HODGKIN DISEASE; HUMAN; MULTIPLE CYCLE TREATMENT; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARIAN TRANSPOSITION; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; OVARY TUMOR; OVULATION INDUCTION; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PRESERVATION; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; TISSUE TRANSPLANTATION; TREATMENT DURATION; TREATMENT INDICATION; WOMEN'S HEALTH;

BREAST NEOPLASMS; CRYOPRESERVATION; FEMALE; FERTILITY; GONADOTROPIN-RELEASING HORMONE; HODGKIN DISEASE; HUMANS; INFERTILITY, FEMALE; OVARIAN NEOPLASMS; OVARY;

EID: 80052310077     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-1874-1     Document Type: Review

References (40)

1. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, American Society of Clinical Oncology (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917-2931 (Pubitemid 46655598)
2. Jeruss JS, Woodruff TK (2009) Preservation of fertility in patients with cancer. N Engl J Med 360:902-911
3. FertiPROTEKT. Website of the "Network for fertility preservation before chemo and radiotherapy", http://www.fertiprotekt.eu. Responsible: Prof. Dr. Michael von Wolff. Installed 01' 2007, Last update 03' 2009
4. Al-Inany HG, Abou-Setta AM, Aboulghar M (2007) Gonadotrophin- releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online 14:640-649
5. von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, Strowitzki T (2009) Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 92:1360-1365
6. Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O (2009) Triggering with human chorionic gonadotropin or a gonadotropin- releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 91:365-371
7. Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, Bang H (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885-3890 (Pubitemid 44536859)
8. Barritt J, Luna M, Duke M, Grunfeld L, Mukheerje T, Sandler B, Copperman AB (2007) Report of four donor-recipient oocyte Cryopreservation cycles resulting in high pregnancy and implantation rates. Fertil Steril 87:189e13-189e17
9. Cobo A, Bellver J, Domingo J, Pérez S, Crespo J, Pellicer A, Remohi J (2008) New options in assisted reproduction technology: the Cryotop method of oocyte vitrification. RBM Online 17:68-72
10. Lawrenz B, Jauckus J, Kupka M, Strowitzki T, von Wolff M (2010) Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases. Fertil Steril (Epub ahead of print)
11. Lawrenz B, Jauckus J, Kupka M, Strowitzki T, von Wolff M (2011) Fertility preservation in [1000 patients - patients characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet (in press)
12. Montag M, Tolba R, Schulz M, Sadek F, van der Ven H (2007) Untersuchungen zum Einfluss des Mediums auf den Transport von Ovarialgewebe im Rahmen der Fertilitätsprotektion. J Reprod Endokrinol 5:264
13. Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, Schmidt KL, Andersen AN, Ernst E (2008) Two successful pregnancies following autotransplantation of frozen/ thawed ovarian tissue. Hum Reprod 23:2266-2272
14. Isachenko V, Isachenko E, Weiss JM, Todorov P, Kreienberg R (2009) Cryobanking of human ovarian tissue for anti-cancer treatment: comparison of vitrification and conventional freezing. Cryo Lett 30:449-454
15. von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, Salle B, Sonmezer M, Andersen CY (2009) Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy - a technique in its infancy but already successful in fertility preservation. Eur J Cancer 45:1547-1553
16. Schmidt KT, Rosendahl M, Ernst E, Loft A, Andersen AN, Dueholm M, Ottosen C, Andersen CY (2010) Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapyinduced premature ovarian failure: the Danish experience. Fertil Steril (Epub ahead of print)
17. Bittinger SE, Nazaretian SP, Gook DA, Parmar C, Harrup RA, Stern CJ (2010) Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril (Epub ahead of print)
18. Sánchez-Serrano M, Novella-Maestre E, Roselló-Sastre E, Camarasa N, Teruel J, Pellicer A (2009) Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Reprod 24:2238-2243
19. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, Slyusarevsky E, Amariglio N, Schiff E, Rechavi G, Nagler A, Ben Yehuda D (2008) Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 23:1007-1013 (Pubitemid 351757322)
20. Blumenfeld Z, von Wolff M (2008) GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14:543-552
21. von Wolff M, Kämmerer U, Kollmann Z, Santi A, Dietl J, Frambach T (2010) Combination of gonadotropin-releasing hormone (GnRH) agonists with GnRH antagonists before chemotherapy reduce but do not completely prevent a folliclestimulating hormone flare-up. Fertil Steril (in press)
22. Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553-561
23. Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, Bastian LA (2009) Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt) 18(3):311-319
24. Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer SM (2010) Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis. Breast Cancer Res Treat 122:803-811
25. Bedaiwy MA, Abou-Setta AM, Desai N, Hurd W, Starks D, El- Nashar SA, Al-Inany HG, Falcone T (2010) Gonadotropinreleasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis. Fertil Steril 95:906-914
26. Olive DL (2008) Gonadotropin-releasing hormone agonists for endometriosis. N Engl J Med 359:1136-1142
27. Huober-Zeeb C, Lawrenz B, Popovici RM, Strowitzki T, Germeyer A, Stute P, von Wolff M (2010) Improving fertility preservation in cancer: ovarian tissue cryobanking followed by ovarian stimulation can be efficiently and safely combined. Fertil Steril (Epub ahead of print)
28. Maman E, Prokopis K, Levron J, Carmely A, Dor J, Meirow D (2009) Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study. Hum Reprod 24:206-210
29. Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Hum Reprod 18:117-121 (Pubitemid 36138861)
30. Wo JY, Viswanathan AN (2009) Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 73:1304-1312
31. Bisharah M, Tulandi T (2003) Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 188:367-370 (Pubitemid 36249972)
32. Bloemers MC, Portelance L, Legler C, Renaud MC, Tan SL (2010) Preservation of ovarian function by ovarian transposition prior to concurrent chemotherapy and pelvic radiation for cervical cancer. A case report and review of the literature. Eur J Gynaecol Oncol 31:194-197
33. Anderson B, LaPolla J, Turner D, Chapman G, Buller R (1993) Ovarian transposition in cervical cancer. Gynecol Oncol 49:206-214 (Pubitemid 23169993)
34. Sankila R, Heinävaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: "healthy mother effect". Am J Obstet Gynecol 170:818-823 (Pubitemid 24224706)
35. Azim AA, Costantini-Ferrando M, Oktay K (2008) Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 26:2630-2635
36. German Hodgkin study group. GHSG Studienzentrale Uniklinik Cologne Kerpener Str. 62 50924 Cologne, Germany. http://www.ghsg.org/
37. Denschlag D, von Wolff M, Amant F, Kesic V, Reed N, Schneider A, Rodolakis A (2010) Fertility preservation in borderline ovarian neoplasm (tumor of low malignant potential): ovarian stimulation and oocyte retrieval after conservative surgery. Gynecol Obstet Invest 70:160-165
38. Fain-Kahn V, Poirot C, Uzan C, Prades M, Gouy S, Genestie C, Duvillard P, Morice P (2009) Feasibility of ovarian cryopreservation in borderline ovarian tumours. Hum Reprod 24:850-855
39. Walshe JM, Denduluri N, Swain S (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24:5769-5779 (Pubitemid 46646480)
40. Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A, German Hodgkin's Lymphoma Study Group (2005) Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 23:7555-7564 (Pubitemid 46291819)